Heidrick & Struggles International, Inc. (HSII)
NASDAQ: HSII · Real-Time Price · USD
43.05
-1.48 (-3.32%)
Aug 1, 2025, 4:00 PM - Market closed
Verve Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Verve Therapeutics stock have a consensus rating of "Buy" and an average price target of $49, which forecasts a 13.82% increase in the stock price over the next year. The lowest target is $46 and the highest is $52.
Price Target: $49.00 (+13.82%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 20, 2025.
Analyst Ratings
The average analyst rating for Verve Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $44 → $46 | Hold | Maintains | $44 → $46 | +6.85% | Jun 20, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $52 | Buy | Maintains | $52 | +20.79% | Jun 13, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $42 → $44 | Hold | Maintains | $42 → $44 | +2.21% | Apr 15, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $50 → $52 | Buy | Maintains | $50 → $52 | +20.79% | Mar 5, 2025 |
| Truist Securities | Truist Securities | Hold Reiterates $40 → $42 | Hold | Reiterates | $40 → $42 | -2.44% | Dec 4, 2024 |
Financial Forecast
Revenue This Year
1.17B
from 1.10B
Increased by 6.41%
Revenue Next Year
1.20B
from 1.17B
Increased by 2.65%
EPS This Year
2.92
from 0.41
Increased by 612.34%
EPS Next Year
3.47
from 2.92
Increased by 18.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 1.2B | 1.3B |
| Avg | 1.2B | 1.2B |
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 11.7% | 7.9% |
| Avg | 6.4% | 2.7% |
| Low | -0.3% | -3.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 3.09 | 3.68 |
| Avg | 2.92 | 3.47 |
| Low | 2.73 | 3.22 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 652.9% | 25.8% |
| Avg | 612.3% | 18.7% |
| Low | 566.9% | 10.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.